Cancer Therapy Satisfaction Questionnaire (CTSQ)

[ Distributed by Mapi Research Trust ]

Author(s)
Pfizer Inc, USA
Purpose
  Pathology:
Neoplasms

  Disease:
Generic for neoplasms

  Objective:
To assess satisfaction with and preference for chemotherapy treatment, and for biological therapy in either pill or IV form

  Population for intended use:
Adult
Characteristics
  Type of instrument:
Patient satisfaction

  Administration mode:
Self-administered

[ Note: the authors require that the original version of the CTSQ be psychometrically validated for a web administration. For more information, please contact us: contact@mapi-trust.org ]

  Number of items:
16

  Existence of database:
No

  Recall/Observation period:
In the last four weeks
 
Language(s)
  Original language:
English for the USA

  List of existing translations:
The translations listed below may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.

This list of translations is subject to constant changes, therefore please check the status of translations with MAPI Research Trust / the developers / copyright holders / distributors

------------------------------------------------------------------------------------------------------------------------------

Dutch for the Netherlands
English for Ireland
German
Spanish
English for Australia
English for UK
Italian
Spanish for the USA
English for Canada
French for Canada
Japanese
Swedish
 


Last update: October 2011
Last update in collaboration with the author: September 2011


Details of the questionnaire
(Restricted access for ProQolid's members)
Subscribe